LLGL1 and ovarian carcinoma: We and others showed that Hugl-1 is down-regulated or completely absent in a wide variety of human epithelial malignancies such as breast, lung, prostate, ovarian cancers and melanomas [32, 35] and it has also been implicated in colorectal cancer progression [36].